133 related articles for article (PubMed ID: 14659917)
21. Improved approach to identify cancer-associated autoantigens.
Fernández Madrid F; Tang N; Alansari H; Karvonen RL; Tomkiel JE
Autoimmun Rev; 2005 Apr; 4(4):230-5. PubMed ID: 15893717
[TBL] [Abstract][Full Text] [Related]
22. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
23. [Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):834-9. PubMed ID: 18476518
[TBL] [Abstract][Full Text] [Related]
24. Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer.
Zhong L; Peng X; Hidalgo GE; Doherty DE; Stromberg AJ; Hirschowitz EA
Proteomics; 2004 Apr; 4(4):1216-25. PubMed ID: 15049001
[TBL] [Abstract][Full Text] [Related]
25. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning.
Jäger D; Taverna C; Zippelius A; Knuth A
Cancer Immunol Immunother; 2004 Mar; 53(3):144-7. PubMed ID: 14727084
[TBL] [Abstract][Full Text] [Related]
26. Characterization of human colon cancer antigens recognized by autologous antibodies.
Scanlan MJ; Chen YT; Williamson B; Gure AO; Stockert E; Gordan JD; Türeci O; Sahin U; Pfreundschuh M; Old LJ
Int J Cancer; 1998 May; 76(5):652-8. PubMed ID: 9610721
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
[TBL] [Abstract][Full Text] [Related]
28. Serological analysis of human renal cell carcinoma.
Devitt G; Meyer C; Wiedemann N; Eichmüller S; Kopp-Schneider A; Haferkamp A; Hautmann R; Zöller M
Int J Cancer; 2006 May; 118(9):2210-9. PubMed ID: 16331622
[TBL] [Abstract][Full Text] [Related]
29. Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma.
Diesinger I; Bauer C; Brass N; Schaefers HJ; Comtesse N; Sybrecht G; Meese E
Int J Cancer; 2002 Dec; 102(4):372-8. PubMed ID: 12402307
[TBL] [Abstract][Full Text] [Related]
30. Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.
Kiyamova R; Garifulin O; Gryshkova V; Kostianets O; Shyian M; Gout I; Filonenko V
Biomarkers; 2012 Jun; 17(4):362-71. PubMed ID: 22612312
[TBL] [Abstract][Full Text] [Related]
31. Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage.
Pavoni E; Vaccaro P; Pucci A; Monteriù G; Beghetto E; Barca S; Dupuis ML; De Pasquale Ceratti A; Lugini A; Cianfriglia M; Cortesi E; Felici F; Minenkova O
BMC Cancer; 2004 Nov; 4():78. PubMed ID: 15541172
[TBL] [Abstract][Full Text] [Related]
32. Exploitation of the B cell repertoire for the identification of human tumor antigens.
Pfreundschuh M
Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
[TBL] [Abstract][Full Text] [Related]
33. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.
Pei L; Liu H; Ouyang S; Zhao C; Liu M; Wang T; Wang P; Ye H; Wang K; Song C; Zhang J; Dai L
Immunobiology; 2020 Mar; 225(2):151891. PubMed ID: 31839396
[TBL] [Abstract][Full Text] [Related]
34. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
Tomkiel JE; Alansari H; Tang N; Virgin JB; Yang X; VandeVord P; Karvonen RL; Granda JL; Kraut MJ; Ensley JF; Fernández-Madrid F
Clin Cancer Res; 2002 Mar; 8(3):752-8. PubMed ID: 11895905
[TBL] [Abstract][Full Text] [Related]
35. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
36. Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.
Stempfer R; Syed P; Vierlinger K; Pichler R; Meese E; Leidinger P; Ludwig N; Kriegner A; Nöhammer C; Weinhäusel A
BMC Cancer; 2010 Nov; 10():627. PubMed ID: 21078204
[TBL] [Abstract][Full Text] [Related]
37. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.
Güre AO; Stockert E; Scanlan MJ; Keresztes RS; Jäger D; Altorki NK; Old LJ; Chen YT
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4198-203. PubMed ID: 10760287
[TBL] [Abstract][Full Text] [Related]
38. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
Hybridoma; 1999 Feb; 18(1):23-8. PubMed ID: 10211784
[TBL] [Abstract][Full Text] [Related]
39. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
[TBL] [Abstract][Full Text] [Related]
40. [Serological study of a repertoire of human cancer antigens and autoantigens].
Koroleva EP; Lagar'kova MA; Khlgatian SV; Shebzukhov IuV; Meshcheriakov AA; lichinitser MR; Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2004; 38(2):233-8. PubMed ID: 15125227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
